While this second study showed lower relative risk than the July study, both confirm an elevated risk
doi: 10.7326/0003-4819-140-10-200405180-00006
The shortage of these drugs has led to a surge in demand for compounded versions of these medications, creating both opportunities and significant risks
Variability in outcomes across studies can be attributed to a range of factors, including demographic, genetic, and environmental differences, as highlighted by various studies [16,17]
The most commonly prescribed GLP-1 medications include: Semaglutide Available as Ozempic (semaglutide) for diabetes and Wegovy (semaglutide) for weight management Tirzepatide Sold as Mounjaro (tirzepatide) for diabetes and Zepbound (tirzepatide) for weight loss Liraglutide Available as Victoza (liraglutide) for diabetes and Saxenda (liraglutide) for weight management Clinical trials demonstrate significant benefits for these medications
10.4103/1477-3163.92308 143 NavidS.FanC.O Flores-VillanuevaD.LiY
